[
  {
    "ts": "2026-01-28T12:23:13+00:00",
    "headline": "Jim Cramer on Cardinal Health: “I Can See That Stock Going to $300”",
    "summary": "Cardinal Health, Inc. (NYSE:CAH) is one of the stocks Jim Cramer discussed, along with market shortages. Mentioning that they like the company, a caller asked for Cramer’s take on it, and he replied: Oh, Jason Hollar. You know it’s funny… I’m out there. You got all these great drug companies, and who am I most […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-cardinal-health-see-122313133.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "0f33c266-e9b1-38af-8637-af9cb31a0eb1",
      "content": {
        "id": "0f33c266-e9b1-38af-8637-af9cb31a0eb1",
        "contentType": "STORY",
        "title": "Jim Cramer on Cardinal Health: “I Can See That Stock Going to $300”",
        "description": "",
        "summary": "Cardinal Health, Inc. (NYSE:CAH) is one of the stocks Jim Cramer discussed, along with market shortages. Mentioning that they like the company, a caller asked for Cramer’s take on it, and he replied: Oh, Jason Hollar. You know it’s funny… I’m out there. You got all these great drug companies, and who am I most […]",
        "pubDate": "2026-01-28T12:23:13Z",
        "displayTime": "2026-01-28T12:23:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/f4972b23ca1d429713741721f81c5f25",
          "originalWidth": 1920,
          "originalHeight": 1280,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RcFryqOLWXyjpn.bSexpBA--~B/aD0xMjgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/f4972b23ca1d429713741721f81c5f25.cf.webp",
              "width": 1920,
              "height": 1280,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/11C66UWKw4HJJjHboXfTPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f4972b23ca1d429713741721f81c5f25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-cardinal-health-see-122313133.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-cardinal-health-see-122313133.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-28T12:46:00+00:00",
    "headline": "PAHC Q2 Earnings Preview: Animal Health Momentum Likely to Aid Results",
    "summary": "Phibro Animal Health heads into Q2 with strong Animal Health momentum, revenues up 15.4% and EPS up 27.8%, as MFA, nutrition and vaccines drive results",
    "url": "https://finance.yahoo.com/news/pahc-q2-earnings-preview-animal-124600088.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "66bbdc26-26e5-324d-a6a6-905b27476a6c",
      "content": {
        "id": "66bbdc26-26e5-324d-a6a6-905b27476a6c",
        "contentType": "STORY",
        "title": "PAHC Q2 Earnings Preview: Animal Health Momentum Likely to Aid Results",
        "description": "",
        "summary": "Phibro Animal Health heads into Q2 with strong Animal Health momentum, revenues up 15.4% and EPS up 27.8%, as MFA, nutrition and vaccines drive results",
        "pubDate": "2026-01-28T12:46:00Z",
        "displayTime": "2026-01-28T12:46:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZwoKmvWtG4m50IBSf0NKDQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LkiDNdOPbO2HoLFk.M.nKA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pahc-q2-earnings-preview-animal-124600088.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pahc-q2-earnings-preview-animal-124600088.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PAHC"
            },
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-28T12:43:00+00:00",
    "headline": "Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings",
    "summary": "Ahead of Q4 earnings, IDXX eyes double-digit revenue and EPS growth, driven by CAG momentum, new diagnostics and steady Water gains.",
    "url": "https://finance.yahoo.com/news/heres-idexx-laboratories-placed-ahead-124300204.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "fb307da7-a907-3bc5-a018-06d51297c650",
      "content": {
        "id": "fb307da7-a907-3bc5-a018-06d51297c650",
        "contentType": "STORY",
        "title": "Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings",
        "description": "",
        "summary": "Ahead of Q4 earnings, IDXX eyes double-digit revenue and EPS growth, driven by CAG momentum, new diagnostics and steady Water gains.",
        "pubDate": "2026-01-28T12:43:00Z",
        "displayTime": "2026-01-28T12:43:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZwoKmvWtG4m50IBSf0NKDQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LkiDNdOPbO2HoLFk.M.nKA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/181d5ab1675d8aae9c53428215552644.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-idexx-laboratories-placed-ahead-124300204.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-idexx-laboratories-placed-ahead-124300204.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "IDXX"
            },
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-28T12:27:00+00:00",
    "headline": "Will Robust MedSurg Performance Fuel Boston Scientific's Q4 Earnings?",
    "summary": "BSX heads into Q4 earnings with strong MedSurg momentum and Cardiovascular growth, as revenue and EPS estimates point to double-digit gains.",
    "url": "https://finance.yahoo.com/news/robust-medsurg-performance-fuel-boston-122700137.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "60e7a8a4-753a-37af-88d9-3a470991c5e9",
      "content": {
        "id": "60e7a8a4-753a-37af-88d9-3a470991c5e9",
        "contentType": "STORY",
        "title": "Will Robust MedSurg Performance Fuel Boston Scientific's Q4 Earnings?",
        "description": "",
        "summary": "BSX heads into Q4 earnings with strong MedSurg momentum and Cardiovascular growth, as revenue and EPS estimates point to double-digit gains.",
        "pubDate": "2026-01-28T12:27:00Z",
        "displayTime": "2026-01-28T12:27:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/863d153925c0cc5950906ad3869a2441",
          "originalWidth": 620,
          "originalHeight": 526,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QnonRcRxvBcES83yw1mIMQ--~B/aD01MjY7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/863d153925c0cc5950906ad3869a2441.cf.webp",
              "width": 620,
              "height": 526,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hpkSOn9LSx9RBAhEDv3QzQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/863d153925c0cc5950906ad3869a2441.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/robust-medsurg-performance-fuel-boston-122700137.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/robust-medsurg-performance-fuel-boston-122700137.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-28T12:26:00+00:00",
    "headline": "STERIS' Q3 Earnings on Deck: What's in Store for the Stock?",
    "summary": "STE enters Q3 earnings with revenues seen up 8% to $1.48B and EPS rising 9.1% to $2.53, supported by strength in Healthcare, AST and Life Sciences.",
    "url": "https://finance.yahoo.com/news/steris-q3-earnings-deck-whats-122600614.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "862bdeb5-74d7-3a3c-bdc3-95e2f5426402",
      "content": {
        "id": "862bdeb5-74d7-3a3c-bdc3-95e2f5426402",
        "contentType": "STORY",
        "title": "STERIS' Q3 Earnings on Deck: What's in Store for the Stock?",
        "description": "",
        "summary": "STE enters Q3 earnings with revenues seen up 8% to $1.48B and EPS rising 9.1% to $2.53, supported by strength in Healthcare, AST and Life Sciences.",
        "pubDate": "2026-01-28T12:26:00Z",
        "displayTime": "2026-01-28T12:26:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/d75c1f3a4ca0523531a6e5515376f55b",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ql.gnzdrLc0CQE9djdB50A--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d75c1f3a4ca0523531a6e5515376f55b.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sZ5dFDl2iSnAW.zL7TxiYw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/d75c1f3a4ca0523531a6e5515376f55b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/steris-q3-earnings-deck-whats-122600614.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/steris-q3-earnings-deck-whats-122600614.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "STE"
            },
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]